期刊文献+

2型糖尿病患者甲状腺功能状态分析 被引量:1

下载PDF
导出
摘要 目的分析2型糖尿病患者甲状腺功能状态。方法对140例2型糖尿病患者的血清游离T3(FT3)、游离T4(FT4)、促甲状腺激素(TSH)进行检测分析,并设正常对照组130例。结果 2型糖尿病组甲状腺功能提示TSH水平升高和FT3水平降低,与正常对照组比较有显著性差异,2型糖尿病患者中,甲状腺功能异常者占28%,其中甲状腺功能减退者占21%,女性2型糖尿病患者,亚临床甲减的患病率(28.1%)显著高于男性。结论 2型糖尿病患者并发甲状腺功能异常较常见,尤以女性亚临床甲减最常见。2型糖尿病患者应常规筛查甲状腺功能,提高亚临床甲减的检出率。
作者 孙丽琴 费扬
机构地区 富阳市人民医院
出处 《浙江实用医学》 2012年第5期342-343,共2页 Zhejiang Practical Medicine
  • 相关文献

参考文献11

  • 1Vondra K, Vrbikova J, Dvorakova K. Thyroid Stand diseasesin adult patients with diabetes mellitus. Minerva Endocrinol. 2005. 30:217.
  • 2张宏,卢军,赵伟,郑凝,谢云,张秋梅,董如娇,方佩华.T2DM合并甲状腺肿患者心血管疾病患病情况的初步探讨[J].天津医科大学学报,2005,11(3):423-425. 被引量:11
  • 3张宏,白景文,赵伟,郑凝,董如娇,卫丽君,方佩华.糖尿病大鼠甲状腺组织的超微病理改变[J].天津医药,2006,34(2):108-110. 被引量:40
  • 4Radaideh A R, Nusier M K, Amari F L, et al. Thyriad dysfunction in pationts with type 2 diabetes mellitus in Jordan. Saudi Med J. 2004, 25:1046.
  • 5Barzilaym J I, Freedland E S. Inflammation and its relationship to insu - lin resistance, type 2 diabetes mellitus, endothelial dysfunction, Metab Syndr Relate Disord, 2003, 1 ( 1 ) : 55.
  • 6Mora C, Navarro J F. the role of inflammation as a pathogenic factor in the development of renal disease in diabetes. Curr Diab Rep, 2005, 5(6) :399.
  • 7Patwardhan N A, Lombardi A. Effect of tumor necrosis factor on growth and function in FRTL5 cells. Surgery, 1991, 110(6):972.
  • 8Wartofsky L, Burman K D. Alterations in thyroid function in patients with systemic illness: the "euthymid sick syndrome". Endocr Rev, 1982, 3:164.
  • 9劳国娟,严励.亚临床甲状腺功能异常的治疗[J].中国实用内科杂志,2010,30(9):866-868. 被引量:19
  • 10刘星君,滕卫平,施秉银,魏丹国,张丽,徐利,李娟.亚临床甲状腺功能异常对血脂的影响[J].中华内科杂志,2010,49(2):151-152. 被引量:10

二级参考文献58

  • 1谢玲玎,高燕明,卢桂芝,蒋秋明,郭晓蕙,高妍.亚临床甲状腺功能减退症与高脂血症及非酒精性脂肪肝的相关性研究[J].中华内分泌代谢杂志,2006,22(6):554-557. 被引量:22
  • 2陈美受 林益川 等.糖尿病并发症与正常甲状腺功能病态综合征[J].实用糖尿病杂志,1994,2(2):42-42.
  • 3Kanaya AM, Harris F, Volpato S, et al. Association between thyroid dysfunction and total cholesterol level in an older biracial population: the health, aging and body composition study. Arch Intern Med,2002,162:773-779.
  • 4Jung CH, Sung KC, Shin HS, et al. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea. Korean J Intern Med, 2003,18:146- 153.
  • 5Pirich C, Milliner M, Sinzinger H. Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants. J Clin Epidemio1,2000,53:623-629.
  • 6Duntas LH. Thyroid disease and lipids. Thyroid, 2002,12:287- 293.
  • 7SurksM I, Ortiz E, Daniels GH, et al. Subclinical thyroid disease : scientific review and guidelines for diagnosisand management[J]. JAMA ,2004,291 (2) :228 -238.
  • 8《中国甲状腺疾病诊治指南》编委会.亚临床甲亢[S].中国甲状腺疾病诊治指南,2008:25-26.
  • 9Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons [ J ]. N Engl J Med,1994,331:1249 - 1252.
  • 10Scorza FA, Arida RM, Cysneiros RM, et al. Subclinical hyperthyroidism and sudden unexpected death in epilepsy[J]. Med Hypot- heses,2010,74(4) :692 -694.

共引文献76

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部